Skip to main content
. 2016 Jan 27;352:i65. doi: 10.1136/bmj.i65

graphic file with name shar027951.f3_default.jpg

Fig 3 Meta-analysis of suicidality in participants receiving selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) compared with placebo post-randomisation